Joseph Raffaele: Can Improving Mitochondrial Quality in Immune Cells Alter Immune Aging Markers?
Joseph Raffaele, Physician-Scientist in Longevity Medicine, CEO of PhysioAge LLC, shared a post on LinkedIn about a recent article by Dominic Denk et al, published in Nature Aging:
”Mitochondria shape immune function over decades.
A recent human trial asked whether we could change this fate.
If we improve mitochondrial quality inside immune cells, can we alter immune aging markers in people?
As immune cells age, mitochondrial dysfunction accumulates.
Damaged mitochondria persist due to impaired mitophagy (damaged mitochondria cleanup).
Energy production declines, reactive oxygen species increase, and immune cells drift toward exhaustion and chronic inflammatory signaling.
In this study, 50 healthy middle-aged adults received 𝟏,𝟎𝟎𝟎 𝐦𝐠/𝐝𝐚𝐲 𝐨𝐟 𝐮𝐫𝐨𝐥𝐢𝐭𝐡𝐢𝐧 𝐀 𝐟𝐨𝐫 𝐟𝐨𝐮𝐫 𝐰𝐞𝐞𝐤𝐬, a compound shown to induce mitophagy and improve mitochondrial quality control.
Primary endpoints focused on phenotypic and metabolic remodeling of peripheral immune cells, rather than nonspecific clinical outcomes.
Participants receiving urolithin A showed:
- An expansion of naïve-like CD8 T cells
- Improved immune cell metabolic flexibility
- Increased mitochondrial biogenesis in key immune populations
Importantly, inflammatory cytokines and immune function were evaluated alongside cellular metabolism, allowing investigators to directly link mitochondrial quality with immune behavior rather than treating them as separate phenomena.
What makes this study important is the template it provides.
Aging biology advances when trials target a known mechanism, measure the right cell populations, and use human-relevant endpoints. This is the kind of evidence that moves geroscience from theory toward clinical practice.”
Title: Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial
Authors: Dominic Denk, Anurag Singh, Herbert G. Kasler, Davide D’Amico, Julia Rey, Lucía Alcober-Boquet, Johanna M. Gorol, Christoph Steup, Ritesh Tiwari, Ryan Kwok, Rafael J. Argüello, Julie Faitg, Kathrin Sprinzl, Stefan Zeuzem, Valentina Nekljudova, Sibylle Loibl, Eric Verdin, Chris Rinsch, Florian R. Greten
Read the Full Article on Nature Aging
Stay updated with Hemostasis Today.
-
May 29, 2026, 04:37Josefin Ahnström: How Andexanet Alfa Impacts TFPIα Function
-
May 29, 2026, 03:19Building Safer Systems for Anticoagulation Management – ISTH
-
May 29, 2026, 03:07Early Diagnosis Can Change the Lives of Women With Haemophilia – EHC
-
May 29, 2026, 02:41Ifeanyichukwu Ifechidere: The Biggest DOAC Myth in Coagulation – ‘No Monitoring Required’
-
May 29, 2026, 02:35Mariam Swidan: Why Is LDH the ‘Tattletale’ of the Lab?
-
May 29, 2026, 02:20Yuntian Wang: Multi-View Learning for Predicting Avatrombopag Response in Pediatric Immune Thrombocytopenia
-
May 29, 2026, 01:57Giuseppina Caligiuri: Pathophysiological Challenges and Emerging Therapeutic Strategies in Acute Stroke
-
May 28, 2026, 23:47Hussnain Javaid: The Importance of Targeted Examination in Iron Deficiency Anaemia
-
May 28, 2026, 23:47ASH Heads to ASCO26 with Career Opportunities and Global Hematology Leadership